Egyszerű nézet

dc.contributor.author Jankovics Péter,
dc.contributor.author Lohner Szilvia,
dc.contributor.author Darcsi, András
dc.contributor.author Németh-Palotás Júlia,
dc.contributor.author Béni, Szabolcs
dc.date.accessioned 2014-11-16T18:03:23Z
dc.date.available 2014-11-16T18:03:23Z
dc.date.issued 2013
dc.identifier 84871897475
dc.identifier.citation pagination=83-91; journalVolume=74; journalTitle=JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/541
dc.identifier.uri doi:10.1016/j.jpba.2012.10.013
dc.description.abstract A new derivative of vardenafil was detected in an alleged herbal dietary supplement and identified as 2-(2-ethoxy-5-(4-(2-hydroxyethyl)piperazin-1-ylsulfonyl)phenyl)-5-methyl-7-propyl-imidazo[1,5-f][1,2,4]triazin-4(3H)-thione. Structure elucidation was carried out by LC–UV–MS/MS and NMR. Results obtained with high resolution MS and IR spectroscopy confirmed the proposed chemical structure. The compound was distinguished from hydroxyvardenafil, a second active substance identified in the same product, by the conversion of the oxo group to a thio group on the imidazo-triazin moiety. Hydroxythiovardenafil was therefore suggested as a proprietary name for the new molecule. This is the first paper to describe a thio-analog of vardenafil in a commercially available product.
dc.relation.ispartof urn:issn:0731-7085
dc.title Detection and structure elucidation of hydroxythiovardenafil as an adulterant in a herbal dietary supplement
dc.type Journal Article
dc.date.updated 2014-11-16T18:02:41Z
dc.language.rfc3066 en
dc.identifier.mtmt 2159533
dc.identifier.wos 000314332300012
dc.identifier.pubmed 23245238
dc.contributor.department SE/GYTK/Gyógyszerészi Kémiai Intézet
dc.contributor.institution Semmelweis Egyetem


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet